Program Committee
The Program Committee is a group of talented and passionate members dedicated to building an impactful program. The committee's collaboration allows ISPOR to deliver a meaningful experience to attendees.
Co-Chairs
Will Canestaro, MSc, PhD
BD and Operations, Stealth Biotech, Teaching Faculty, UW Foster School of Business, Venture Partner, Pack Ventures Labs, Seattle, WA, USA
Jen Fine, PhD
SVP, Evidence Generation & HEOR, Abivax, San Francisco, CA, USA
Melanie Whittington, PhD
Head, Leerink Center for Pharmacoeconomics, Boston, MA, USA
Members
Kirsten Axelsen, MS
Senior Policy Advisor, DLA Piper, New York, NY, USA
Frank S. David, MD, PhD
Managing Director, Pharmagellan, Milton, MA and Professor of the Practice of Biotechnology, Department of Biology, Tufts University, Medford, MA, USA
Doug Foster, MBA
Partner, Advanced Data Sciences LLC, San Francisco, CA, USA
Erik J. Landaas, PhD, MPH
Global Director HEOR & Market Access, W.L. Gore & Associates, Ponte Vedra, FL, USA
Meng Li, PhD
Researcher, Tufts Medical Center, The Center for the Evaluation of Value and Risk in Health, Boston, MA, USA
Sorochi Van Sickle, PhD
Senior Research Associate, EMPIRIC Institute, Patient Square Capital, San Francisco, CA, USA
Richard Xie, PhD
Senior Health Economist, RA Capital, Boston, MA, USA